179 related articles for article (PubMed ID: 11991753)
1. Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice.
Elliger SS; Elliger CA; Lang C; Watson GL
Mol Ther; 2002 May; 5(5 Pt 1):617-26. PubMed ID: 11991753
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
Watson GL; Sayles JN; Chen C; Elliger SS; Elliger CA; Raju NR; Kurtzman GJ; Podsakoff GM
Gene Ther; 1998 Dec; 5(12):1642-9. PubMed ID: 10023443
[TBL] [Abstract][Full Text] [Related]
4. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice.
Ohashi T; Watabe K; Uehara K; Sly WS; Vogler C; Eto Y
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1287-92. PubMed ID: 9037045
[TBL] [Abstract][Full Text] [Related]
6. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
Bosch A; Perret E; Desmaris N; Heard JM
Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
Hennig AK; Ogilvie JM; Ohlemiller KK; Timmers AM; Hauswirth WW; Sands MS
Mol Ther; 2004 Jul; 10(1):106-16. PubMed ID: 15233947
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
[TBL] [Abstract][Full Text] [Related]
9. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression.
Kosuga M; Takahashi S; Sasaki K; Li XK; Fujino M; Hamada H; Suzuki S; Yamada M; Matsuo N; Okuyama T
Mol Ther; 2000 May; 1(5 Pt 1):406-13. PubMed ID: 10933961
[TBL] [Abstract][Full Text] [Related]
11. Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector.
Elliger SS; Elliger CA; Aguilar CP; Raju NR; Watson GL
Gene Ther; 1999 Jun; 6(6):1175-8. PubMed ID: 10455422
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
13. Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice.
Orii KO; Grubb JH; Vogler C; Levy B; Tan Y; Markova K; Davidson BL; Mao Q; Orii T; Kondo N; Sly WS
Mol Ther; 2005 Aug; 12(2):345-52. PubMed ID: 16043103
[TBL] [Abstract][Full Text] [Related]
14. A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings.
Vogler C; Levy B; Galvin N; Sands MS; Birkenmeier EH; Sly WS; Barker J
Pediatr Res; 2001 Mar; 49(3):342-8. PubMed ID: 11228259
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
Bielicki J; McIntyre C; Anson DS
Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369
[TBL] [Abstract][Full Text] [Related]
16. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
Gao C; Sands MS; Haskins ME; Ponder KP
Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
[TBL] [Abstract][Full Text] [Related]
17. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.
Skorupa AF; Fisher KJ; Wilson JM; Parente MK; Wolfe JH
Exp Neurol; 1999 Nov; 160(1):17-27. PubMed ID: 10630187
[TBL] [Abstract][Full Text] [Related]
18. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
[TBL] [Abstract][Full Text] [Related]
19. Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.
Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez M; Dieter T; Holden CC; Sukegawa K; Orii T; Kondo N; Sly WS
Hum Mol Genet; 2003 May; 12(9):961-73. PubMed ID: 12700165
[TBL] [Abstract][Full Text] [Related]
20. Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII.
Cadaoas J; Boyle G; Jungles S; Cullen S; Vellard M; Grubb JH; Jurecka A; Sly W; Kakkis E
Mol Genet Metab; 2020 May; 130(1):65-76. PubMed ID: 32192868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
